INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
124 hedge funds and large institutions have $442M invested in Insys Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-14
Holders Change %
-10.14%
% of All Funds
3.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
13
Increased
39
Reduced
45
Closed
26
Calls
$2.74M
Puts
$13.4M
Net Calls
-$10.7M
Net Calls Change
-$9.97M
Top Buyers
| 1 |
HP
1
HealthInvest Partners
Stockholm,
Sweden
|
$10.2M |
| 2 |
FCM
2
Freshford Capital Management
Rye Brook,
New York
|
$6.16M |
| 3 |
3
Goldman Sachs
New York
|
$8.46M |
| 4 |
4
Renaissance Technologies
New York
|
$2.97M |
| 5 |
5
Millennium Management
New York
|
$3.83M |
